The DOI matches its Crossref record; 127 of the 128 references it cites were found in a registry or an index.
Engineering Adolescence: Maturation of Human Pluripotent Stem Cell–Derived Cardiomyocytes
Open accessAbstract
The discovery of human pluripotent stem cells (hPSCs), including both human embryonic stem cells and human-induced pluripotent stem cells, has opened up novel paths for a wide range of scientific studies. The capability to direct the differentiation of hPSCs into functional cardiomyocytes has provided a platform for regenerative medicine, development, tissue engineering, disease modeling, and drug toxicity testing. Despite exciting progress, achieving the optimal benefits has been hampered by the immature nature of these cardiomyocytes. Cardiac maturation has long been studied in vivo using animal models; however, finding ways to mature hPSC cardiomyocytes is only in its initial stages. In this review, we discuss progress in promoting the maturation of the hPSC cardiomyocytes, in the context of our current knowledge of developmental cardiac maturation and in relation to in vitro model systems such as rodent ventricular myocytes. Promising approaches that have begun to be examined in hPSC cardiomyocytes include long-term culturing, 3-dimensional tissue engineering, mechanical loading, electric stimulation, modulation of substrate stiffness, and treatment with neurohormonal factors. Future studies will benefit from the combinatorial use of different approaches that more closely mimic nature’s diverse cues, which may result in broader changes in structure, function, and therapeutic applicability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These values are comparable to those observed in tissues composed of immature cells where cell geometry, calcium handling, gap junction expression and spatial distribution, as well as other factors limit the conduction velocity when compared to mature tissues52,53.”
From A tissue-engineered scale model of the heart ventricle (2018) · cites this paper as [53]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Commonly, immature hPSC-CMs exhibit a positive chronotropic response to β-adrenergic stimulation but lack the positive inotropy characteristic of adult cardiomyocytes (Yang et al., 2014).”
From A human engineered mini-heart platform for mimicking ventricular pump function (2025) · cites this paper as Yang et al., 2014
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“However, these CMs are immature compared to their in vivo counterparts.”
From Single-cell RNA sequencing reveals maturation trajectory in human pluripotent stem cell-derived cardiomyocytes in engineered tissues (2023) · cites this paper as [10]
The cited source says what the claim attributes to it.
In the citing paper
“a number of major hallmarks have been regarded as a general consensus of the field, including myofibril maturation, electrophysiology, calcium handling, metabolic maturation, hypertrophy, and integration of physiology.10,37,38”
From Single-cell RNA sequencing reveals maturation trajectory in human pluripotent stem cell-derived cardiomyocytes in engineered tissues (2023) · cites this paper as [10]
The cited source says what the claim attributes to it.
In the citing paper
“Adult CMs are characterized by distinctive features including rod-like shape, polyploidy and organized myofibrils, mitochondrial networks, sarcoplasmic reticulum, and T-tubules.10,21”
From Single-cell RNA sequencing reveals maturation trajectory in human pluripotent stem cell-derived cardiomyocytes in engineered tissues (2023) · cites this paper as [10]
In the citing paper
“Biowire, with a more matured phenotype and a closer recapitulation of the adult native cardiac tissue, is considered to have more predictive power for cardiotoxicity screening [247].”
From Cardiovascular disease models: A game changing paradigm in drug discovery and screening (2019) · cites this paper as [247]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors
Ieda, M., Fu, J.-D., Delgado-Olguin, P., Vedantham, V., Hayashi, Y., Bruneau, B. G., & Srivastava, D. (2010) · Cell · doi:10.1016/j.cell.2010.07.002 · Cited by 2,454
Thyroid hormone and the cardiovascular system.
Klein, I., & Ojamaa, K. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102153440707 · Cited by 2,300
Regulation of cardiac hypertrophy by intracellular signalling pathways
Heineke, J., & Molkentin, J. D. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1983 · Cited by 1,890
Control of Stress-Dependent Cardiac Growth and Gene Expression by a MicroRNA
van Rooij, E., Sutherland, L. B., Qi, X., Richardson, J. A., Hill, J. A., & Olson, E. N. (2007) · Science · doi:10.1126/science.1139089 · Cited by 1,666
Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells
Zhang, J., Wilson, G. F., Soerens, A. G., Koonce, C. H., Yu, J., Palecek, S. P., Thomson, J. A., & Kamp, T. J. (2009) · Circulation Research · doi:10.1161/circresaha.108.192237 · Cited by 1,426
In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes
Li, Q., Huang, Y., Spencer, C. I., Foley, A., Vedantham, V., Liu, L., Conway, S. J., Fu, J., & Srivastava, D. (2012) · Nature · doi:10.1038/nature11044 · Cited by 1,376
Laflamme, M. A., & Murry, C. E. (2011) · Nature · doi:10.1038/nature10147 · Cited by 1,272
Self-citationPatient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome
Moretti, A., Bellin, M., Welling, A., Jung, C. B., Lam, J. T., Bott-Flügel, L., Dorn, T., Goedel, A., Höhnke, C., Hofmann, F., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908679 · Cited by 1,251
Heart repair by reprogramming non-myocytes with cardiac transcription factors
Song, K., Nam, Y., Luo, X., Qi, X., Tan, W. H., Huang, G. N., Acharya, A., Smith, C. L., Tallquist, M. D., Neilson, E. G., et al. (2012) · Nature · doi:10.1038/nature11139 · Cited by 1,162
Mummery, C., Ward-van Oostwaard, D., Doevendans, P., Spijker, R., van den Brink, S., Hassink, R., van der Heyden, M., Opthof, T., Pera, M., de la Riviere, A. B., et al. (2003) · Circulation · doi:10.1161/01.cir.0000068356.38592.68 · Cited by 1,001
Cited by
Sorted by citations
Items 301–400 of 938
Esser, T. U., Roshanbinfar, K., & Engel, F. B. (2018) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2019.1561855 · Cited by 40
Fiber Scaffold Patterning for Mending Hearts: 3D Organization Bringing the Next Step
Kristen, M., Ainsworth, M. J., Chirico, N., van der Ven, C. F. T., Doevendans, P. A., Sluijter, J. P. G., Malda, J., van Mil, A., & Castilho, M. D. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201900775 · Cited by 40
Hochman‐Mendez, C., de Campos, D. B. P., Pinto, R. S., Mendes, B. J. D. S., Rocha, G. M., Monnerat, G., Weissmüller, G., Sampaio, L. C., Carvalho, A. B., Taylor, D. A., et al. (2020) · Journal of Tissue Engineering · doi:10.1177/2041731420921482 · Cited by 40
High content analysis identifies unique morphological features of reprogrammed cardiomyocytes
Sutcliffe, M. D., Tan, P. M., Fernandez-Perez, A., Nam, Y., Munshi, N. V., & Saucerman, J. J. (2018) · Scientific Reports · doi:10.1038/s41598-018-19539-z · Cited by 39
Biermann, M., Cai, W., Lang, D., Hermsen, J., Profio, L., Zhou, Y., Czirók, A., Isai, D. G., Napiwocki, B. N., Rodriguez, A. M., et al. (2019) · Stem Cells · doi:10.1002/stem.3021 · Cited by 40
Mechanotransduction and Metabolism in Cardiomyocyte Microdomains
Pasqualini, F. S., Nesmith, A. P., Horton, R. E., Sheehy, S. P., & Parker, K. K. (2016) · BioMed Research International · doi:10.1155/2016/4081638 · Cited by 41
Liang, Y., Zhang, X., Zhou, Q., Tan, B., Xu, H., Yi, Q., Liang, Y., Xie, M., Zhang, Y., Tian, J., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.644667 · Cited by 40
Barbuti, A., & Robinson, R. B. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.009597 · Cited by 38
Bioengineering Approaches to Mature Human Pluripotent Stem Cell-Derived Cardiomyocytes
Sun, X., & Nunes, S. S. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00019 · Cited by 43
Bhute, V. J., Bao, X., Dunn, K. K., Knutson, K. R., McCurry, E. C., Jin, G., Russell, W. L., Lewis, S., Ikeda, A., & Palecek, S. P. (2017) · Theranostics · doi:10.7150/thno.19390 · Cited by 40
Cardiomyogenesis Modeling Using Pluripotent Stem Cells: The Role of Microenvironmental Signaling
Leitolis, A., Robert, A. W., Pereira, I. T., Correa, A., & Stimamiglio, M. A. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00164 · Cited by 41
Multicellular In vitro Models of Cardiac Arrhythmias: Focus on Atrial Fibrillation
van Gorp, P. R. R., Trines, S. A. I. P., Pijnappels, D. A., & de Vries, A. A. F. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00043 · Cited by 39
Sympathetic Neurons Regulate Cardiomyocyte Maturation in Culture
Kowalski, W. J., Garcia-Pak, I. H., Li, W., Uosaki, H., Tampakakis, E., Zou, J., Lin, Y., Patterson, K., Kwon, C., & Mukouyama, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.850645 · Cited by 38
Li, J., Feng, X., & Wei, X. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02905-0 · Cited by 42
Vascularisation to improve translational potential of tissue engineering systems for cardiac repair
Dilley, R. J., & Morrison, W. A. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.10.020 · Cited by 38
Subtype-specific cardiomyocytes for precision medicine: Where are we now?
Zhao, M., Shao, N., & Garg, V. (2020) · Stem Cells · doi:10.1002/stem.3178 · Cited by 39
Gong, Y., Chen, Z., Li, Y., Ai, X., Yan, B., Wang, H., Qiu, L., Tan, Y., Witman, N., Wang, W., et al. (2020) · ACS Nano · doi:10.1021/acsnano.0c01745 · Cited by 37
Use of automated patch clamp in cardiac safety assessment: past, present and future perspectives
Bell, D. C., & Fermini, B. (2021) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2021.107072 · Cited by 38
In vitro models of the human heart
Hofbauer, P., Jahnel, S. M., & Mendjan, S. (2021) · Development · doi:10.1242/dev.199672 · Cited by 39
HIF signaling: A new propellant in bone regeneration
Bai, H., Wang, Y., Zhao, Y. D., Chen, X., Xiao, Y. M., & Bao, C. (2022) · Biomaterials Advances · doi:10.1016/j.bioadv.2022.212874 · Cited by 37
Kanda, Y., Yamazaki, D., Kurokawa, J., Inutsuka, T., & Sekino, Y. (2016) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2016.06.007 · Cited by 37
Automated Contraction Analysis of Human Engineered Heart Tissue for Cardiac Drug Safety Screening
Mannhardt, I., Saleem, U., Benzin, A., Schulze, T., Klampe, B., Eschenhagen, T., & Hansen, A. (2017) · Journal of Visualized Experiments · doi:10.3791/55461 · Cited by 37
Human Embryonic Stem Cells vs Human Induced Pluripotent Stem Cells for Cardiac Repair
Barad, L., Schick, R., Zeevi‐Levin, N., Itskovitz‐Eldor, J., & Binah, O. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.06.023 · Cited by 36
Stem cells and heart disease - Brake or accelerator?
Steinhoff, G., Nesteruk, J., Wolfien, M., Große, J., Ruch, U., Vasudevan, P., & Müller, P. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.10.007 · Cited by 37
Lopez, C. A., Al-Siddiqi, H., Purnama, U., Iftekhar, S., Bruyneel, A. A. N., Kerr, M. J., Nazir, R., Fialho, M. D. L. S., Malandraki-Miller, S., Alonaizan, R., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-87186-y · Cited by 36
Deogharia, M., Venegas-Zamora, L., Agrawal, A., Shi, M., Jain, A. K., McHugh, K. J., Altamirano, F. J., Marian, A. J., & Gurha, P. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvae014 · Cited by 36
Patient-Specific Induced Pluripotent Stem Cells for Disease Modeling and Phenotypic Drug Discovery
Tang, S., Xie, M., Cao, N., & Ding, S. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00789 · Cited by 37
Zuppinger, C., Gibbons, G. M., Dutta-Passecker, P., Segiser, A., Most, H., & Suter, T. M. (2017) · European Journal of Histochemistry · doi:10.4081/ejh.2017.2763 · Cited by 37
Swift, L., Burke, M., Guerrelli, D., Reilly, M., Ramadan, M., McCullough, D., Prudencio, T. M., Mulvany, C., Chaluvadi, A., Jaimes, R., et al. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00521.2019 · Cited by 35
Engineering Human Cardiac Muscle Patch Constructs for Prevention of Post-infarction LV Remodeling
Wang, L., Serpooshan, V., & Zhang, J. J. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.621781 · Cited by 35
HiPS-Endothelial Cells Acquire Cardiac Endothelial Phenotype in Co-culture With hiPS-Cardiomyocytes
Helle, E., Ampuja, M., Dainis, A., Antola, L., Temmes, E., Tolvanen, E., Mervaala, E. M. A., & Kivelä, R. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.715093 · Cited by 35
Ly, O. T., Chen, H., Brown, G. E., Hong, L., Wang, X., Han, Y. D., Pavel, M. A., Sridhar, A., Maienschein‐Cline, M., Chalazan, B., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.155640 · Cited by 35
Engineering Cardiac Tissue for Advanced Heart‐On‐A‐Chip Platforms
Chen, X., Liu, S., Han, M., Long, M., Li, T., Hu, L., Wang, L., Huang, W., & Wu, Y. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202301338 · Cited by 35
van Deel, E. D., Najafi, A., Fontoura, D., Valent, E. T., Goebel, M., Kardux, K., Falcão‐Pires, I., & van der Velden, J. (2017) · The Journal of Physiology · doi:10.1113/jp274460 · Cited by 34
Engineering cardiac microphysiological systems to model pathological extracellular matrix remodeling
Ariyasinghe, N. R., Lyra‐Leite, D. M., & McCain, M. L. (2018) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00110.2018 · Cited by 36
Multifunctional Bioinstructive 3D Architectures to Modulate Cellular Behavior
Vaithilingam, J., Sanjuan‐Alberte, P., Campora, S., Rance, G. A., Jiang, L., Thorpe, J., Burroughs, L., Tuck, C. J., Denning, C. N., Wildman, R. D., et al. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201902016 · Cited by 35
Wijnker, P. J. M., & van der Velden, J. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165774 · Cited by 34
Mechanobiology Assays with Applications in Cardiomyocyte Biology and Cardiotoxicity
Blair, C. A., & Pruitt, B. L. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.201901656 · Cited by 35
Titin Circular RNAs Create a Back-Splice Motif Essential for SRSF10 Splicing
Tijsen, A. J., Ortega, L. C., Reckman, Y. J., Zhang, X., van der Made, I., Aufiero, S., Li, J., Kamps, S. C., van den Bout, A., Devalla, H. D., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.050455 · Cited by 34
Control of cardiomyocyte differentiation timing by intercellular signaling pathways
Rowton, M., Guzzetta, A., Rydeen, A. B., & Moskowitz, I. P. G. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.06.002 · Cited by 37
The harder the climb the better the view: The impact of substrate stiffness on cardiomyocyte fate
Querceto, S., Santoro, R., Gowran, A., Grandinetti, B., Pompilio, G., Regnier, M., Tesi, C., Poggesi, C., Ferrantini, C., & Pioner, J. M. (2022) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2022.02.001 · Cited by 37
Correia, C. D., Ferreira, A., Fernandes, M. T., Silva, B. M., Esteves, F., Leitão, H. S., Bragança, J., & Calado, S. M. (2023) · Cells · doi:10.3390/cells12131727 · Cited by 38
Huethorst, E., Hortigon-Vinagre, M. P., Zamora, V., Reynolds, P. M., Burton, F. L., Smith, G. L., & Gadegaard, N. (2016) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6b00426 · Cited by 34
Proteolysis regulates cardiomyocyte maturation and tissue integration
Fukuda, R., Gunawan, F., Beisaw, A., Jiménez-Amilburu, V., Maischein, H., Sawa Kostin, D., Kawakami, K., & Stainier, D. Y. R. (2017) · Nature Communications · doi:10.1038/ncomms14495 · Cited by 34
Developing miRNA therapeutics for cardiac repair in ischemic heart disease
Zhu, K., Liu, D., Lai, H., Li, J., & Wang, C. (2016) · Journal of Thoracic Disease · doi:10.21037/jtd.2016.08.93 · Cited by 33
Geometry-Dependent Arrhythmias in Electrically Excitable Tissues
McNamara, H. M., Dodson, S., Huang, Y., Miller, E. W., Sandstede, B., & Cohen, A. E. (2018) · Cell Systems · doi:10.1016/j.cels.2018.08.013 · Cited by 33
The Role of Reactive Oxygen Species in In Vitro Cardiac Maturation
Momtahan, N., Crosby, C. O., & Zoldan, J. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.04.005 · Cited by 33
Homma, J., Shimizu, S., Sekine, H., Matsuura, K., & Shimizu, T. (2020) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.3074 · Cited by 33
Ni, X., Xu, K., Zhao, Y., Li, J., Wang, L., Yu, F., & Li, G. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.11.076 · Cited by 34
Serna, J. A., Rueda-Gensini, L., Céspedes-Valenzuela, D. N., Cifuentes, J., Cruz, J. C., & Muñoz-Camargo, C. (2021) · Polymers · doi:10.3390/polym13193263 · Cited by 33
Animal models for SARS‐CoV‐2 infection and pathology
Bi, Z., Hong, W., Yang, H. J., Lu, S., & Peng, X. (2021) · MedComm · doi:10.1002/mco2.98 · Cited by 35
Chirico, N., Kessler, E. L., Maas, R. G. C., Fang, J., Qin, J., Dokter, I., Daniels, M., Šarić, T., Neef, K., Buikema, J. W., et al. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03209-z · Cited by 35
Shawky, J. H., Balakrishnan, U. L., Stuckenholz, C., & Davidson, L. A. (2018) · Development · doi:10.1242/dev.161281 · Cited by 32
Fabre, K. M., Delsing, L., Hicks, R., Colclough, N., Crowther, D. C., & Ewart, L. C. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.09.009 · Cited by 32
Unchain My Heart: Integrins at the Basis of iPSC Cardiomyocyte Differentiation
Santoro, R., Perrucci, G. L., Gowran, A., & Pompilio, G. (2019) · Stem Cells International · doi:10.1155/2019/8203950 · Cited by 34
Expansion Culture of Human Pluripotent Stem Cells and Production of Cardiomyocytes
Le, M. N. T., & Hasegawa, K. (2019) · Bioengineering · doi:10.3390/bioengineering6020048 · Cited by 32
Progress in Bioengineering Strategies for Heart Regenerative Medicine
Häneke, T., & Sahara, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073482 · Cited by 32
Stein, J. M., Arslan, U., Franken, M., de Greef, J. C., Harding, S. E., Mohammadi, N., Orlova, V. V., Bellin, M., Mummery, C. L., & van Meer, B. J. (2022) · Current Protocols · doi:10.1002/cpz1.462 · Cited by 32
Pluripotent Stem Cell‐Based Platforms in Cardiac Disease Modeling and Drug Testing
Shaheen, N., Shiti, A., & Gepstein, L. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.722 · Cited by 32
Kerr, C. M., Richards, D., Menick, D. R., DeLeon‐Pennell, K. Y., & Mei, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168482 · Cited by 31
Hunkler, H. J., Groß, S., Thum, T., & Bär, C. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab335 · Cited by 31
Contractility and Calcium Transient Maturation in the Human iPSC-Derived Cardiac Microfibers
Strimaityte, D., Tu, C., Yanez, A., Itzhaki, I., Wu, H., Wu, J. C., & Yang, H. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c07326 · Cited by 31
Cui, C., Wang, J., Qian, D., Huang, J., Lin, J., Kingshott, P., Wang, P., & Chen, M. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b17090 · Cited by 31
Yoshida, S., Sumomozawa, K., Nagamine, K., & Nishizawa, M. (2019) · Macromolecular Bioscience · doi:10.1002/mabi.201900060 · Cited by 32
Breckwoldt, K., Weinberger, F., & Eschenhagen, T. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.11.010 · Cited by 31
Liu, L., Xu, F., Jin, H., Qiu, B., Yang, J., Zhang, W., Gao, Q., Lin, B., Chen, S., & Sun, D. (2023) · Bioengineering · doi:10.3390/bioengineering10060702 · Cited by 30
Piezo-bending actuators for isometric or auxotonic contraction analysis of engineered heart tissue
Mannhardt, I., Warncke, C., Trieu, H. K., Müller, J. W., & Eschenhagen, T. (2018) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2755 · Cited by 30
Unveiling the molecular crosstalk in a human induced pluripotent stem cell‐derived cardiac model
Abecasis, B., Gomes‐Alves, P., Rosa, S. C., Gouveia, P., Ferreira, L., Serra, M., & Alves, P. M. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.26929 · Cited by 30
Pluripotent Stem Cell-Derived Cardiomyocyte Transplantation for Heart Disease Treatment
Kadota, S., & Shiba, Y. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1171-3 · Cited by 30
Wu, P., Sai, X., Li, Z., Ye, X., Li, J., Liu, G., Li, G., Yang, P., Zhao, M., Zhu, S., et al. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.05.024 · Cited by 31
Paoletti, C., Divieto, C., & Chiono, V. (2018) · Cells · doi:10.3390/cells7090114 · Cited by 30
Sarikhani, M., Garbern, J. C., Ma, S., Sereda, R., Conde, J., Krähenbühl, G., Escalante, G. O., Ahmed, A., Buenrostro, J. D., & Lee, R. T. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.06.012 · Cited by 30
Engineered Maturation Approaches of Human Pluripotent Stem Cell-Derived Ventricular Cardiomyocytes
Ge, F., Wang, Z., & Xi, J. (2019) · Cells · doi:10.3390/cells9010009 · Cited by 29
Zhang, X., Liang, Y., Xu, H., Zhou, Q., Tan, B., Yi, Q., Liang, Y., Xie, M., Zhang, Y., Tian, J., et al. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02264-2 · Cited by 29
Huang, G., Bisaria, A., Wakefield, D. L., Yamawaki, T., Luo, X., Zhang, J. A., Vigneault, P., Wang, J., Reagan, J. D., Oliverio, O., et al. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.11.008 · Cited by 30
Miyagawa, S., Fukushima, S., Imanishi, Y., Kawamura, T., Mochizuki‐Oda, N., Masuda, S., & Sawa, Y. (2016) · Current Gene Therapy · doi:10.2174/1566523216666160119094143 · Cited by 29
Maturation of Human Stem Cell-derived Cardiomyocytes in Biowires Using Electrical Stimulation
Sun, X., & Nunes, S. S. (2017) · Journal of Visualized Experiments · doi:10.3791/55373 · Cited by 29
Syncytium cell growth increases Kir2.1 contribution in human iPSC-cardiomyocytes
Li, W., Han, J., & Entcheva, E. G. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00148.2020 · Cited by 29
Current Status of Cardiac Regenerative Therapy Using Induced Pluripotent Stem Cells
Sugiura, T., Shahannaz, D. C., & Ferrell, B. E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115772 · Cited by 31
Kosmidis, G., Bellin, M., Ribeiro, M. C., van Meer, B. J., Oostwaard, D. W., Passier, R. C., Tertoolen, L. G. J., Mummery, C. L., & Casini, S. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.10.026 · Cited by 28
hiPSCs in cardio-oncology: deciphering the genomics
Pinheiro, E. A., Fetterman, K. A., & Burridge, P. W. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz018 · Cited by 28
Biendarra‐Tiegs, S. M., Clemens, D. J., Secreto, F. J., & Nelson, T. J. (2019) · Stem Cells and Development · doi:10.1089/scd.2019.0098 · Cited by 28
Mending a broken heart: In vitro, in vivo and in silico models of congenital heart disease
Rufaihah, A. J., Chen, C. K., Yap, C. H., & Mattar, C. N. Z. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.047522 · Cited by 31
Hsueh, Y., Pratt, R. E., Dzau, V. J., & Hodgkinson, C. P. (2023) · Scientific Reports · doi:10.1038/s41598-023-31144-3 · Cited by 28
Rogers, A. J., Fast, V. G., & Sethu, P. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.6b03105 · Cited by 28
Spitalieri, P., Talarico, R. V., Caioli, S., Murdocca, M., Serafino, A., Girasole, M., Dinarelli, S., Longo, G., Pucci, S., Botta, A., et al. (2018) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2018.03.012 · Cited by 28
Lu, H. R., Zeng, H., Kettenhofen, R. F., Guo, L., Kopljar, I., Ammel, K. V., Tekle, F. B., Teisman, A. C. H., Zhai, J., Clouse, H., et al. (2019) · Toxicological Sciences · doi:10.1093/toxsci/kfz102 · Cited by 28
Vuorenpää, H., Penttinen, K., Heinonen, T., Pekkanen-Mattila, M., Sarkanen, J., Ylikomi, T. J., & Aalto‐Setälä, K. (2017) · Cytotechnology · doi:10.1007/s10616-017-0088-1 · Cited by 27
Lin, Y., Liu, H., Klein, M. G., Ostrominski, J. W., Hong, S. G., Yada, R. C., Chen, G., Navarengom, K., Schwartzbeck, R., San, H., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-24074-y · Cited by 27
Kahn-Krell, A. M., Pretorius, D., Ou, J., Fast, V. G., Litovsky, S. H., Berry, J. L., Liu, X., & Zhang, J. J. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.674260 · Cited by 27
Hartogh, S. C. D., & Passier, R. C. (2015) · Stem Cells · doi:10.1002/stem.2196 · Cited by 27
Discovery and progress of direct cardiac reprogramming
Kojima, H., & Ieda, M. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2466-4 · Cited by 28
Tomlinson, L. J., Lu, Z. Q., Bentley, R. A., Colley, H. E., Murdoch, C., Webb, S. D., Cross, M. J., Copple, I. M., & Sharma, P. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108637 · Cited by 27
Correction of DMD in human iPSC-derived cardiomyocytes by base-editing-induced exon skipping
Wang, P., Bailin, P. L., Zhu, M., Han, R. Y., Guo, S., & Han, R. (2022) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2022.11.010 · Cited by 29
Identification of cardiovascular lineage descendants at single-cell resolution
Li, G., Plonowska‐Hirschfeld, K. A., Rajarajan, K., Sturzu, A. C., & Wu, S. M. (2015) · Development · doi:10.1242/dev.116897 · Cited by 26
Clinical-based Cell Therapies for Heart Disease—Current and Future State
Turner, D., Rieger, A. C., Balkan, W., & Hare, J. M. (2020) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10401 · Cited by 26
Pushp, P., Nogueira, D. E. S., Rodrigues, C. A. V., Ferreira, F. C., Cabral, J. M. S., & Gupta, M. K. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-10061-2 · Cited by 27
Maturing heart muscle cells: Mechanisms and transcriptomic insights
Murphy, S. A., Chen, E. Z., Tung, L., Boheler, K. R., & Kwon, C. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.04.019 · Cited by 27
Engineering the Cellular Microenvironment of Post-infarct Myocardium on a Chip
Khalil, N. N., & McCain, M. L. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.709871 · Cited by 27
How Functional Genomics Can Keep Pace With VUS Identification
Anderson, C. L., Munawar, S., Reilly, L., Kamp, T. J., January, C. T., Delisle, B. P., & Eckhardt, L. L. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.900431 · Cited by 26
Metadata
- Authors
- Yang, X., Pabon, L., & Murry, C. E.
- Affiliations
- University of Washington (US)
- Venue
- Circulation Research
- Published
- 2014-01-31
- Volume
- 114
- Issue
- 3
- Pages
- 511-523
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- PMC
- PMC3955370
- OpenAlex
- W2033765226
- Semantic Scholar
- d50fb63e8e68ab0d845e62dbf5f9c8c2470174d7
- Cited by
- 939
- References
- 128
- Citations by year
- 2026: 31 · 2025: 44 · 2024: 60 · 2023: 76 · 2022: 76 · 2021: 96 · 2020: 99 · 2019: 106 · 2018: 85 · 2017: 103 · 2016: 68 · 2015: 76 · 2014: 19
- FWCI
- 8.36
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation Research (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (U01HL100405, P01HL094374, R01HL084642)
- National Institute of General Medical Sciences (P01GM081619)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Keywords
- human pluripotent stem cells, cardiomyocyte maturation, human embryonic stem cells, induced pluripotent stem cells, cardiac differentiation, 3D tissue engineering, mechanical loading, electrical stimulation, substrate stiffness, neurohormonal factors, disease modeling, drug toxicity testing, regenerative medicine
- MeSH terms
- Animals, Cell Differentiation, Cells, Cultured, Genetic Engineering, Humans, Time Factors, Models, Animal, Myocytes, Cardiac, Pluripotent Stem Cells, Induced Pluripotent Stem Cells, Cell Engineering
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
